Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
UNITAID and ANRS launch initiative in Cameroon to bring new HIV treatments to Africa

A study launched in Yaoundé will test the latest generation of HIV treatment based on Dolutegravir under local conditions, with a view to establishing its viability in Africa. The results of the study are intended to inform the World Health Organization’s guidelines for the treatment of HIV patients in Africa. If successful, they will help to accelerate the opening of the market for these combinations to manufacturers of generic medicines and thereby reduce prices as well as improve access.

Published
17 November 2016
From
UNITAID
Reuters–along with many other news sites–parrots erroneous news release on HIV testing via USB stick

This Reuters story draws readers in with news that scientists have developed a quick HIV test on a USB stick, which could be useful in the developing world. The story confuses the effectiveness of the traditional, test tube-based method with that of the experimental USB stick test that researchers hope will replace it, ultimately overstating the latter’s sensitivity. The reason this happened is because it seems to be based entirely on a news release, which also seems to misunderstand the study’s design.

Published
15 November 2016
From
Health News Review
The ‘long tail’ problem: injected-PrEP trial will be extended due to persistence of drug in companion study

A study presented at last month’s HIV Research for Prevention (HIVR4P) conference in Chicago shows that in a minority of subjects who were given an experimental

Published
11 November 2016
By
Gus Cairns
J&J vaccine plus Gilead immune booster shows promise as HIV fighter

An experimental HIV vaccine from Johnson & Johnson combined with an immune system booster from Gilead Sciences Inc showed promise at keeping the virus at bay in monkeys even after treatments had stopped, marking yet another step toward the development of a so-called functional cure for HIV.

Published
10 November 2016
From
Reuters
Tenofovir alafenamide works well and improves kidney and bone markers in older people living with HIV

A co-formulation of tenofovir alafenamide (TAF) plus emtricitabine, used with a third antiretroviral drug, maintained viral suppression as well as tenofovir disoproxil fumarate (TDF) plus emtricitabine in older

Published
10 November 2016
By
Liz Highleyman
‘Hard’ Brexit would delay access to new drugs, warns report

UK patients could see delays in access to new medicines if Brexit means leaving the single market, warns a new report published by think tank Public Policy Projects backed by health consultancy giant QuintilesIMS.

Published
09 November 2016
From
Pharma Times
Smoking more harmful than HIV for people taking effective treatment, US study suggests

Smoking has the potential to shorten the life of a person taking HIV treatment by an average of six years, and is far more harmful to

Published
08 November 2016
By
Keith Alcorn
Dolutegravir regimen highly effective in clinical trial for women

A once-daily regimen containing the potent HIV integrase inhibitor dolutegravir worked better than an older atazanavir-containing regimen – with higher rates of viral suppression both overall and across

Published
07 November 2016
By
Liz Highleyman
Ibalizumab monoclonal antibody looks promising for people with drug-resistant HIV

Ibalizumab, an experimental monoclonal antibody with a unique mechanism of action, demonstrated good safety and promising efficacy in a small phase 3 study of people with extensive

Published
04 November 2016
By
Liz Highleyman
Smoking may shorten the lifespan of people living with HIV more than HIV itself

Smoking may shorten the lifespan of people living with HIV more than HIV itselfEurekAlert (press release)A new study led by researchers at Massachusetts General Hospital (MGH) finds that cigarette smoking substantially reduces the lifespan of people living with HIV in the U.S., potentially even more than HIV itself.

Published
03 November 2016
From
EurekAlert (press release)

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.